Weilun Ye

Title: Weilun Ye: Innovator in Sustained-Release Drug Delivery

Introduction

Weilun Ye is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative work focuses on the development of sustained-release formulations that enhance therapeutic efficacy.

Latest Patents

Weilun Ye holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight, ensuring effective drug delivery.

Career Highlights

Weilun Ye is associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he applies his expertise in microsphere technology to advance pharmaceutical applications. His work has been instrumental in developing innovative drug delivery systems that improve patient outcomes.

Collaborations

Weilun Ye collaborates with talented professionals in his field, including colleagues Bin Chen and Xia Yin. Their combined efforts contribute to the ongoing research and development of advanced pharmaceutical technologies.

Conclusion

Weilun Ye's contributions to the field of sustained-release drug delivery exemplify the importance of innovation in pharmaceuticals. His patented work on aripiprazole microspheres showcases his commitment to enhancing therapeutic efficacy through advanced drug delivery systems.